Decreased fibrinogen concentration or impaired fibrinogen function can lead to hemorrhage. Thus fibrinogen testing is frequently utilized in the setting of trauma, surgery, disseminated intravascular coagulopathy, and fibrinolytic treatment to determine the need for replacement product. Congenital decreases in fibrinogen…
Along with prothrombin time (PT), activated partial thromboplastin time (PTT) serves as a common screening test for coagulation factor deficiencies. The test is sensitive to significantly decreased activities of so-called intrinsic (FXI, FIX, FVIII), common (FX, FV, FII, and fibrinogen),…
Prothrombin time (PT) was one of the first generated in vitro tests of the hemostasis system. It measures the time to form a fibrin clot in platelet-poor plasma stimulated with high amount of tissue factor (TF) and anionic phospholipid at the…
The human hemostasis system is complex and tightly regulated. The maintenance of adequate blood flow, interrupted only by formation of temporary thrombi localized to places of injury, requires coordination between endothelium, platelets, white blood cells, and numerous soluble plasma elements.…